Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Blocking LFA-1 prevents hair loss in mice.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Blocking interferon-gamma might help treat various autoimmune diseases.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Anifrolumab helped a woman with severe lupus achieve remission when other treatments failed.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.